Jibing Chen

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

Yan Xu, Zheng Xiang, Mohammed Alnaggar et al. · Cellular and Molecular Immunology · 2020 · 232 citations · Full text

The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells

Yilin Zhao, Su Zhang, Jianyin Zhou et al. · Biomaterials · 2009 · 148 citations

Tissue Engineering, Regenerative Medicine, Vascular Tissue Engineering +11

Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients

Mao Lin, Haihua Luo, Shuzhen Liang et al. · Journal of Clinical Investigation · 2020 · 132 citations · Full text

Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

Mohammed Alnaggar, Yan Xu, Jingxia Li et al. · Journal for ImmunoTherapy of Cancer · 2019 · 125 citations · Full text

Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients

Mao Lin, Xiaoyan Zhang, Shuzhen Liang et al. · Signal Transduction and Targeted Therapy · 2020 · 88 citations · Full text